You are here

AusPAR: Tocilizumab (rch)

Related information


How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

3 September 2020
AusPAR Details
AusPAR
Active Ingredient
Tocilizumab (rch)
Product Name
Actemra
Sponsor
Roche Products Pty Limited
Submission Number
PM-2018-05341-1-3
Submission Type
Extension of indications
Decision
Approved
AusPAR Date
18 August 2020
Publication Date

3 September 2020